Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mark Sydenham"'
Autor:
Adrian Murray Brunt, Joanne S Haviland, Duncan A Wheatley, Mark A Sydenham, Abdulla Alhasso, David J Bloomfield, Charlie Chan, Mark Churn, Susan Cleator, Charlotte E Coles, Andrew Goodman, Adrian Harnett, Penelope Hopwood, Anna M Kirby, Cliona C Kirwan, Carolyn Morris, Zohal Nabi, Elinor Sawyer, Navita Somaiah, Liba Stones, Isabel Syndikus, Judith M Bliss, John R Yarnold, Anne Armstrong, Judith Bliss, David Bloomfield, Jo Bowen, Murray Brunt, Hannah Chantler, Charlotte Coles, Ellen Donovan, Andy Goodman, Susan Griffin, Jo Haviland, Penny Hopwood, Anna Kirby, Julie Kirk, Cliona Kirwan, Marjory MacLennan, Mark Sculphur, Judith Sinclair, Mark Sydenham, Jean Tremlett, Karen Venables, Duncan Wheatley, John Yarnold
Publikováno v:
Lancet (London, England)
FAST-Forward Trial Management Group 2020, ' Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward) : 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial ', Lancet (London, England), vol. 395, no. 10237, pp. 1613-1626 . https://doi.org/10.1016/S0140-6736(20)30932-6
FAST-Forward Trial Management Group 2020, ' Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward) : 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial ', Lancet (London, England), vol. 395, no. 10237, pp. 1613-1626 . https://doi.org/10.1016/S0140-6736(20)30932-6
BACKGROUND: We aimed to identify a five-fraction schedule of adjuvant radiotherapy (radiation therapy) delivered in 1 week that is non-inferior in terms of local cancer control and is as safe as an international standard 15-fraction regimen after pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e395035946033bfb3c8db03e2d044a
Autor:
Christy, Goldsmith, Joanne, Haviland, Yat, Tsang, Mark, Sydenham, John, Yarnold, Duncan, Wheatley
Publikováno v:
Radiotherapy and Oncology. 100:236-240
Background and Purpose: Large breast size is associated with an increased risk of late adverse effects after breast conservation surgery and radiotherapy, even when 3D dosimetry is used. The purpose of this study is to test the hypothesis that residu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e42e34180934cca7b5cae9f45e96117
https://doi.org/10.1016/j.radonc.2010.12.012
https://doi.org/10.1016/j.radonc.2010.12.012
Autor:
Susan Bradley, Peter N. Lowe, Richard H. Skinner, David J. Cooper, Mark Sydenham, Martin John Page
Publikováno v:
Biochemical Society Transactions. 20:484-487
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e4aee5f7a094d434ec88cbc3c45a225
https://doi.org/10.1042/bst0200484
https://doi.org/10.1042/bst0200484
Salmonella enterica Serovar Typhimurium surA Mutants Are Attenuated and Effective Live Oral Vaccines
A previously described attenuated TnphoAmutant (BRD441) ofSalmonella entericaserovar Typhimurium C5 (I. Miller, D. Maskell, C. Hormaeche, K. Johnson, D. Pickard, and G. Dougan, Infect. Immun. 57:2758–2763, 1989) was characterized, and the transposo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::708e7b05c6fef3d28bc863f186b0a1e6
https://europepmc.org/articles/PMC97255/
https://europepmc.org/articles/PMC97255/
Publikováno v:
Biology of Salmonella ISBN: 9781461362364
Defined mutations in such genes as aroA, purA and ompR have been shown to attenuate Salmonella species, and strains harbouring such mutations make good, single dose oral vaccine strains (O’Callaghan et al 1988, Dorman et al 1989, Chatfield et al 19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce398c7b514b2e10dbac6eff587308d5
https://doi.org/10.1007/978-1-4615-2854-8_55
https://doi.org/10.1007/978-1-4615-2854-8_55
Autor:
Mark Sydenham, Susan Hoare, Malcolm G. Parker, Roger White, Stephen E. Fawell, Martin John Page
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America. 87(17)
Many estrogen-antagonist and -agonist ligands have been synthesized, some of which have proved clinically important in the treatment of hormone-dependent breast tumors and endocrine disorders. Here we show that the "pure" antiestrogen ICI 164,384 inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59d8aaca67544867e7b9b8d925dcc055
https://pubmed.ncbi.nlm.nih.gov/2395882
https://pubmed.ncbi.nlm.nih.gov/2395882